Thu. Mar 4th, 2021

NAFDAC Approves AstraZeneca Vaccine For Use In Nigeria.

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of the Oxford/AstraZeneca COVID-19 vaccine in Nigeria.

The Director-General of NAFDAC, Dr. Mojisola Adeyeye made the announcement during a live briefing on Thursday.

She said that the vaccine can be stored at 2 to 8-degree centigrade.

A health worker prepares an injection of the AstraZeneca/Oxford Covid-19 vaccine on February 7, 2021 at the Mignot Hospital in Le Chesnay near Paris. PHOTO: ALAIN JOCARD / AFP

According to the NAFDAC Boss, there are three additional vaccines undergoing evaluation, but the evaluation on Astrazeneca shows that the vaccine is effective against the UK variant of the virus which has been reported in Nigeria.

NAFDAC DG, Dr. Mojisola Adeyeye addressing journalists on Thursday, February 18, 2021.

Dr Adeyeye disclosed that the South African variant has not been reported in Nigeria, adding that the agency has over 30 herbal medicine undergoing review for listing.

The vaccine was recently approved by the W.H.O for emergency use, in a press briefing, NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.

The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine. Scientists used an adenovirus, originally derived from chimpanzees, and modified it with the aim of training the immune system to mount a strong response against SARS-CoV-2 (the virus that causes COVID-19).

It is only the second COVID-19 jab to have received WHO authorisation, after the Pfizer-BioNTech vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *